Position in EXEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,992
New position
Shares Held
55
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#691
of 739 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026MANNING & NAPIER ADVISORS LLC holds $1,077,898 across 13 Biotechnology names. EXEL ranks #8 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,064 | $1,025,250 | |
| 2 | INCY |
Incyte Corp
|
92 | $10,429 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
170 | $9,727 | |
| 4 | INVA |
Innoviva, Inc.
|
353 | $8,016 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
26 | $4,869 | |
| 6 | MRNA |
Moderna, Inc.
|
56 | $3,921 | |
| 7 | TECH |
BIO-TECHNE Corp
|
52 | $3,673 | |
| 8 | EXEL |
Exelixis, Inc.
This page
|
55 | $2,992 |
All Filings in EXEL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,992 | 55 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||